Bicalutamide (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Bicalutamide drug offered from Cadila Healthcare Limited. This Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Bicalutamide |
SUBSTANCE NAME: | BICALUTAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-07-06 |
END MARKETING DATE: | 0000-00-00 |
Bicalutamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Bicalutamide from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2009-07-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-613_ed3c2c8f-dfae-403e-baa3-10d3686737e3 |
PRODUCT NDC: | 65841-613 |
APPLICATION NUMBER: | ANDA079089 |
Other BICALUTAMIDE Pharmaceutical Manufacturers / Labelers: